1 66200sek
0,3 %
Date:2026-01-23Time:18:00:00Latest report:Q3-2025List:Large CapTicker:AZN
Market Cap:2 577 609 msekEnterprise Value:2 803 271 msekNet Sales:58 127 musdEarnings:9 399 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 662,00
MA50:1 705,01
MA200:1 501,61
Price/MA200:10,7 %
RSI (14):43,7
Price/MA50:-2,5 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.

Pharmaceuticals